| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Schaffer David is a Director at 4D Molecular Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 17 sells.
Estimated insider holdings value: $10.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 22, 2021 | FDMT 4d Molecular Therapeutics, Inc. | Director | Sell | 36,285 | $31.36 | $1,137,819.21 | -1.3% | -53.9% | -78.9% | |
| Sep 30, 2021 | FDMT 4d Molecular Therapeutics, Inc. | Director | Sell | 29,256 | $27.89 | $815,863.26 | -0.6% | -21.6% | -70.2% | |
| Sep 28, 2021 | FDMT 4d Molecular Therapeutics, Inc. | Director | Sell | 33,244 | $31.90 | $1,060,518.15 | -0.7% | -28.2% | -70.5% | |
| Jan 28, 2020 | QURE Uniqure N.V. | Director | Sell | 806 | $62.27 | $50,189.62 | -1.8% | - | - | |
| Jan 28, 2019 | QURE Uniqure N.V. | Director | Sell | 1,210 | $31.31 | $37,885.10 | -2.6% | - | - | |
| Jan 17, 2019 | QURE Uniqure N.V. | Director | Sell | 7,500 | $30.71 | $230,325.00 | -14.6% | - | - | |
| Jan 29, 2018 | QURE Uniqure N.V. | Director | Sell | 2,878 | $18.53 | $53,329.34 | -15.8% | - | - |